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Abstract
Background: In many parts of the world, the exponential growth rate of infections during the initial epidemic
phase has been used to make statistical inferences on the reproduction number, R, a summary measure of the
transmission potential for the novel influenza A (H1N1) 2009. The growth rate at the initial stage of the epidemic
in Japan led to estimates for R in the range 2.0 to 2.6, capturing the intensity of the initial outbreak among school-
age children in May 2009.
Methods: An updated estimate of R that takes into account the epidemic data from 29 May to 14 July is provided.
An age-structured renewal process is employed to capture the age-dependent transmission dynamics, jointly
estimating the reproduction number, the age-dependent susceptibility and the relative contribution of imported
cases to secondary transmission. Pitfalls in estimating epidemic growth rates are identified and used for scrutinizing
and re-assessing the results of our earlier estimate of R.
Results: Maximum likelihood estimates of R using the data from 29 May to 14 July ranged from 1.21 to 1.35. The
next-generation matrix, based on our age-structured model, predicts that only 17.5% of the population will
experience infection by the end of the first pandemic wave. Our earlier estimate of R did not fully capture the
population-wide epidemic in quantifying the next-generation matrix from the estimated growth rate during the
initial stage of the pandemic in Japan.
Conclusions: In order to quantify R from the growth rate of cases, it is essential that the selected model captures
the underlying transmission dynamics embedded in the data. Exploring additional epidemiological information will
be useful for assessing the temporal dynamics. Although the simple concept of R is more easily grasped by the
general public than that of the next-generation matrix, the matrix incorporating detailed information (e.g., age-
specificity) is essential for reducing the levels of uncertainty in predictions and for assisting public health
policymaking. Model-based prediction and policymaking are best described by sharing fundamental notions of
heterogeneous risks of infection and death with non-experts to avoid potential confusion and/or possible misuse
of modelling results.
Background
The reproduction number, R, the average number of
secondary cases generated by a typical (or “average”)
single primary case, of influenza A (H1N1) 2009 is a
summary measure of the transmission potential in the
population of interest. It has been estimated using the
early epidemic growth data in different locations across
the world [1-12]. The estimations have been based pri-
marily on models that include one or a limited number
of aspects of heterogeneous transmission. The scientific
community has been attracted to R because it provides
a first aggregated measure of the overall transmissibility
of an emerging infection [13]. Further, the estimate of
R, based on homogeneously or nearly homogeneously
mixing population models that by design ignore most
individual differences, is not only used to assess the
initial growth of an epidemic but also the extent to
which the population will experience infection by the
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end of a first pandemic wave [14,15]. Except for a
unique study estimating R using a data set of interna-
tional spread [7], the exponential growth rate, r, of cases
during the initial epidemic phase has been investigated
using a simple procedure that involves translating r into
R through the use of the estimator R = 1/M(-r) where
M(-r) is the moment-generating function of the genera-
tion time distribution, given the growth rate r [16].
Naturally, the higher the growth rate r of the number of
cases, the larger the estimate of R.
The majority of R estimates for this ongoing pandemic
have ranged from 1.1-1.8 [17] while our estimate of R in
Japan was in the range of 2.0-2.6 under the assumption
of a mean generation time of 1.9 days through May
2009 [5]. The most plausible reason for this estimate, as
noted in our earlier study [5], involved the role of initial
conditions as the very early growth was driven by the
high contact rates that are common to school settings
[17,18]. In addition to the phenomenological explana-
tion, it is important to assess whether or not the metho-
dology used to estimate R was adequate. We do this
here using data that go beyond those used in our esti-
mation of R for the earlier epidemic period of May 2009
in Japan. Here we provide an updated estimate of R for
the novel influenza A (H1N1) 2009 in Japan, summaris-
ing the relevant methodological issues in estimating R
from the growth rate of cases and initiating a dialogue
on how estimates of the transmission potential should
be shared with non-experts, including the general
public.
Discussion
The epidemic data in Japan
Figure 1 shows the epidemic curve of influenza A
(H1N1) 2009 for Japan from May to July 2009. Starting
with the illness onset of an index case on 5 May, 4986
confirmed cases, all diagnosed by means of RT-PCR,
were reported to the government during this period. On
22 July, the Ministry of Health, Labour and Welfare of
Japan decided not to mandate its local health sectors to
notify all the confirmed cases, and thereafter the local
sectors gradually ceased counting all the cases. The first
pandemic wave in Japan continued to grow steadily
thereafter hitting the first peak in November [19].
Since our original data indicate that the 97.5 percen-
tile point of the reporting delay distribution (i.e., the
time from illness onset to notification) is 8 days, we
analyse a total of 3480 cases that developed the disease
on or before 14 July. Figure 1A shows the temporal dis-
tribution stratified by age-group of all identified cases.
Of the 3480 cases, 67.0% were among individuals 19
years of age or less. The population of those aged from
20-39 years accounted for 24.2% of the total, and the
remaining (older adult) cases accounted for only 8.8%.
The contributions from imported cases to the early epi-
demic growth in this island nation, in addition to the
local (indigenous) transmissions, are also critical (Figure
1B). Of the 3840 confirmed cases, 694 (19.9%) had a his-
tory of overseas travel within 10 days preceding the
onset of illness, and we refer to them as imported cases
in the present study.
Growth rates of two different phases
We proceed to compare two different growth rates (Fig-
ure 2) in order to explore the patterns that led to our
past R estimates for Japan in [5]. The growth rates of
cases in the very initial phase (i.e., from 5 to 17 May),
which corresponds to the period examined in our earlier
study [5], and those that followed the generation of sec-
ondary cases caused by school clusters (i.e., from 29
May to 14 July) are compared. Over these periods we
observe that the proportion of cases attributed to the 0-
19 age grouping decreased from 83.0% to 67.0%.
We model the expected value of the incidence of ill-
ness onset at calendar time t as E(c(t)) = kexp(r(t-τ))
where k is a constant, r is the growth rate of the corre-
sponding period, and τ is the starting time point of
Figure 1 Temporal distribution of confirmed cases of influenza
A (H1N1) 2009 virus infection in Japan from May to July 2009
(n = 3,480). All the confirmed cases were diagnosed by RT-PCR.
The horizontal axis represents the date of onset. Cases are stratified
by (A) age and (B) travel history. Here “cases with travel history” are
associated with overseas travel within 10 days preceding onset of
illness and those with such a history are referred to as imported
cases in our analysis.
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exponential growth (assumed as 5 May and 29 May,
respectively). Minimizing the sum of squares between the
observed data and expectation, r is estimated as 0.37 and
0.08 per day, respectively, for the former and latter peri-
ods. The estimate for the former period is smaller than
that reported in our earlier study in May (i.e., 0.47 per
day) [5], because of our use of refined dates of onset and
the use of a simpler statistical method in the present
study. The estimates of the exponential growth rates differ
by almost a factor of five (i.e., 0.37/0.08) in the two win-
dows in time, indicating that the cases in the former per-
iod experienced a 1.3 times greater daily growth rate (i.e.,
exp(0.37)/exp(0.08)) than those in the latter period. A
glance at the age-specific data show that the disease spread
from an initial cluster that mix primarily in an assortative
manner into the “general” Japanese population is the most
likely key to this dramatic difference. Since the latter per-
iod reflects the early population-wide spread of H1N1
involving the entire Japanese community, R for this period
is estimated using the following methodology.
Modelling methods
We employ an age-structured model to derive an esti-
mate for R since the transmission of influenza A
(H1N1) 2009 is known to differ greatly among age
groups [1,3,5,9]. Spatial heterogeneity, social heterogene-
ity (e.g. differing patterns of transmission between
household-, school- and workplace-settings), or potential
changes in behaviour are mostly ignored.
The square matrix with generic entry Rij, the average
number of secondary cases in age-group i generated by
a single primary case in age-group j, is referred to as the
next-generation matrix [20]. The reproduction number
R is defined as the dominant eigenvalue of the next-gen-
eration matrix [21]. Since the observed data come as
daily reports, we consider the incidence of indigenous,
ci, t, and imported cases, bi, t, of age-group i developing
the disease on day t in discrete time. Using Rij, the
multi-type renewal process, yielding the conditional
expectation of indigenous cases on day t, is written as
E( , ,..., , , , ..., )
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where a is the relative contribution of imported cases
to secondary transmission as compared to indigenous
cases (0 ≤ a ≤ 1) and gs is the discretized density func-
tion of the generation time of length s days. We intro-
duce the relative reduction a because the physical
movements of those with a history of overseas travel
were partly restricted during the early epidemic phase in
Japan, reducing the number of secondary transmissions.
Also, the imported cases most often developed the dis-
ease shortly before or after entering Japan. The density
of the generation time, gs, is calculated as follows:
g G s G ss   ( ) ( )1 (2)
where G(s) is the cumulative distribution function of
the generation time distribution, which we assume to be
known and to follow a gamma distribution. In the early
modelling studies, the mean generation time was esti-
mated at 1.9 days [1], 2.6-3.2 days [3] and 2.5 days [4].
From contact tracing data in the Netherlands, the mean
and standard deviation (SD) were estimated at 2.7 and
1.1 days, respectively [22]. We adopt 2.7 days as the
mean and fix the coefficient of variation to 40.7% as cal-
culated from the Dutch study. We partly address issues
of uncertainty by measuring the sensitivity of R to differ-
ing mean generation times ranging from 2.1 to 3.3 days.
Rij is modelled as
R Rs mij i ij (3)
where R is the reproduction number to be estimated (i.
e., scalar quantity), si measures the susceptibility of age-
group i given a contact, and mij is the frequency of contact
made by an individual in age-group j with that in i (which
is assumed known and is extracted from a contact survey
in the Netherlands [23]); let S and M be square matrices. S
is the diagonal matrix in which the diagonal elements (i, i)
are si and the entries outside the main diagonal are all
zero. The (i, j) element of M is mij with which we adopt
frequency-dependent assumption, and we ignore more
detailed contact including the “type” and “duration” [24].
We normalize the product SM (i.e., the dominant eigenva-
lue of SM is set to 1) so that R scales the next-generation
matrix. We aggregate the population into six discrete age
groups (0-5, 6-12, 13-19, 20-39, 40-59 years and 60 and
Figure 2 Simple extrapolation of the exponential growth of
cases. Two exponential fits are compared with the observed
number of confirmed cases. Exponential fit 1 employs the data set
from 5 May to 17 May during which clusters of cases in a few high
schools fuelled the epidemic. Exponential fit 2 draws the best fit to
the data from 29 May to 14 July representing the spread of
influenza into the wider population. The growth rates for fits 1 and
2 are estimated at 0.37 and 0.08 per day, respectively.
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older) in order to be able to adhere to the precision of the
contact survey [23]; consequently, the next-generation
matrix has dimensions 6 × 6 (36 elements).
We estimate eight parameters (i.e., R, a and si for six
age-groups) using the renewal equation (1). We assume
that variations in secondary transmissions are appropri-
ately captured by a Poisson distribution [25]. The condi-
tional likelihood of observing ci, t on day t given the
series of foregoing indigenous cases cj, 0, cj, 1, ..., cj, t-1
and of imported cases bj, 0, bj, 1, ..., bj, t-1, respectively,
for all age-groups j, is given by
L c c c c b b b
ci t
ci
i t j j j t j j j t( , ,..., , , , ..., )
E( , )
, , , , , , ,0 1 1 0 1 1 
 , exp( E( , ))
, !
t ci t
ci t
 (4)
where E(ci, t) is the conditional expectation (i.e., the
right-hand side of (1)) and ci, t is the observed number
of cases of age-group i on day t. Maximum likelihood
estimates of the parameters are obtained by minimizing
the negative logarithm of (4) with the 95% confidence
intervals (CI) derived from profile likelihood.
Modelling results
Figure 3 compares the observed and predicted numbers
of confirmed cases. The conditional expectation
approximately captures the observed age-specific pat-
terns of incidence. The maximum likelihood estimate of
the next-generation matrix, Rij, is
K 
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(5)
Those aged from 13-19 years appear to be able to
maintain the transmission by themselves (i.e., meeting
the definition of maintenance host, R33 > 1 [26]). Never-
theless, age groups 1 and 2, children aged from 0-12
years, appear incapable of maintaining transmission (i.e.,
the dominant eigenvalue of the 2 × 2 matrix involving
transmissions among and between those aged from 0-5
and 6-12 years is less than 1). The maximum likelihood
estimate of R is 1.28 (95% CI: 1.23, 1.33). The relative
contribution of imported cases to secondary transmis-
sion, a, is estimated at 0.15 (standard error = 0.14).
Figure 4A examines the sensitivity of R to different
mean generation times. If we adopt 2.1 days as the
mean, R is estimated at 1.21 (95% CI: 1.16, 1.26). If we
adopt 3.3 days, R is 1.35 (95% CI: 1.30, 1.41). Figure 4B
captures relative susceptibilities, using those aged from
20-39 years to define the susceptibility baseline. The
age-groups 0-5, 6-12 and 13-19 years appear to be 2.77
(95% CI: 2.35, 3.24), 2.67 (95% CI: 2.41, 2.95) and 2.76
(95% CI: 2.55, 2.98) times more susceptible than adults
aged 20-39 years. On the other hand, those aged from
40-59 years and 60 years and older are 0.56 (95% CI:
0.45, 0.68) and 0.17 (95% CI: 0.09, 0.28) times as suscep-
tible than those aged 20-39 years. It should be noted
that the qualitative pattern of age-dependent susceptibil-
ity agrees well with the results of immunological studies
[27,28] and a hypothesis about its underlying mechan-
isms [29].
Limitation of the growth rate r
As expected from the greatly differing exponential
growth rates between early May and from 29 May to 14
July (Figure 2), the reproduction number for the latter
period, ranging from 1.21 to 1.35, is much smaller than
our previously reported estimate for the former time
period when the transmission was mainly confined to
school settings [5]. The estimate in the latter period is
consistent with the estimates of R in other countries
Figure 3 Model prediction. Observed (dots) and predicted (lines) age-specific numbers of confirmed cases as a function of onset time are
compared. The prediction on day t was conditioned on observations from days 0 to (t-1).
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[14,16]. The situation is not straightforward, however, as
the estimation was carried out using confirmed cases
(which may be biased towards severe cases). Further, it
should be noted that various interventions, including
reactive school closure and contact tracing, were insti-
tuted during the whole period of observation, so the R
value for the latter period and especially the entries Rij
involving school children might potentially lead to
underestimates for R in the present study.
Since the small outbreak in the former time period
was restricted to a limited number of schools and the
contacts made by the students in Osaka and Kobe (and
as Japan was unique in successfully “containing” the
local school-based outbreak before actual pandemic
overshoot), the depletion of susceptibles in May and
undiagnosed cases are unlikely to have played a signifi-
cant role in our estimates of a smaller R for the epi-
demic in the latter transmission period, which saw the
pandemic takeover. Rather, as we discussed above, the
local networks of interactions (i.e., transmission within
networks that connect to other networks in time), and
consequently the initial conditions (i.e., which network
gets infected first), played a key role in our estimates for
the initial outbreak growth. The earlier estimates of R
captured the initial role in the generation of secondary
cases from schools where the frequency of transmission
among school children greatly exceeded those of the
community (and the “type” of their contact is perhaps
more dense (or close) than those in the community
[24,30]). Although the sensitivity of R to differing mean
generation times was examined within a relatively nar-
row range, this aspect could not account for the high R
estimates obtained in Japan [5].
One important conclusion is drawn from the present
study. The lessons learnt from our estimation over the
two windows in time has forced us to revisit the role of
using summary statistics to characterize transmission
potential from the data generated by heterogeneous
contact patterns. As a network expands, the structure of
networks involved in transmission changes, and conse-
quently the summary statistics of cases, also change in
time [13]. The initial summary statistics therefore
depend in a rather critical way on the initial conditions
(i.e., where and how the disease was introduced) [31],
which is not always captured well by homogeneous mix-
ing models. Since the very early stage of this epidemic
alone involves primarily a few specific sub-groups of the
population, it is difficult to quantify the next-generation
matrix fully and estimate a reproduction number that
adequately captures the transmission potential for the
entire population. Whereas the next-generation matrix
includes representative levels of population heterogene-
ity, the infected individuals during the very initial epi-
demic stage were clearly not representative of the entire
population of interest. The use of the next-generation
matrix involves the introduction of a “typical” infectious
individual into the population, but such an individual
cannot be properly characterized if the matrix involves
unavoidable approximations (due to limited availability
of structured data) when an outbreak happens to be
mostly confined to a single cluster whose average indivi-
dual is “atypical” of the entire population.
The previously reported expected value, R = 2.3, for
the May outbreak might well approximate the intensity
of transmissions in schools (and indeed, is consistent
with the estimate in school settings in the USA [3]).
This is another example of what is often referred as
core group effects in the epidemiological literature [32].
Naturally, the use of the empirical data from school
clusters does not provide sufficient information to carry
out precise estimation of the age-dependent next-gen-
eration matrix, so the resulting dominant eigenvalue in
the earlier study should not be regarded as R but rather
as a measure of transmissibility conditioned on the
initial conditions. The need for the collection of addi-
tional data may be critical when age-specific
Figure 4 Parameter estimates and sensitivity analysis. Panel A examines the sensitivity of the reproduction number to different mean
lengths of the generation time ranging from 2.1 to 3.3 days. Panel B shows the estimate of the age-specific relative susceptibility. The expected
value of susceptibility for those aged 20-39 years was taken as the reference. In both panels, the whiskers extend to the upper and lower 95%
confidence intervals based on the profile likelihood.
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transmission is highly assortative and/or when age-spe-
cific susceptibility is highly heterogeneous (as is the case
for influenza A (H1N1) 2009). Summary statistics based
on highly aggregated populations are in general not
helpful in identifying the pressure points of a heteroge-
neous network, which is essential in the identification
and assessment of the most effective (e.g., age-specific)
intervention policies. In other words, the finer details of
epidemic data (i.e., epidemiological information at a
local level, e.g., active surveillance of cases) need to be
taken into account in the modelling. Not only school
outbreaks, but also other social factors and settings (e.g.
transportation, hospital settings and mass gatherings)
can play enhancing or reducing transmission roles.
In addition to the challenges posed by our need to
average over different levels of heterogeneous mixing,
quantification of the growth rates involves the additional
challenges that come from underreporting, notably
ascertainment of cases and reporting bias. Further,
imputation of onset dates for missing data is sometimes
required, and moreover, the time-varying reporting fre-
quency may even call for naïve adjustment of the
growth rate of confirmed cases by the growth rate of
hospitalized (or other severe portions of) cases [4]. The
data set we examined in Japan involved contact tracing
efforts at all local levels, so the growth rate of confirmed
symptomatic cases is thought to have captured the
actual increase in infection appropriately. Nevertheless,
achieving precise estimation of incidence for this mild
disease remains an open question, particularly if the
proportion of asymptomatic infections among the total
of infected individuals is high.
Is the epidemic growth rate useless?
Despite our earlier suggestion of the “biased” estimate of
the next-generation matrix, it should be noted that we
do not argue that the early growth rate is no longer be
used but rather that the context of its use when appro-
priate should be clarified. The growth rate of cases is, as
with most inferences from statistical modelling, context
dependent (e.g., presence of initially infected cluster).
Given the precise estimate of the generation time distri-
bution, the exponential growth rate is appropriately
translated to the reproduction number for a single
population [16]. This is also the case, for example, for
the multi-type epidemic as outlined below. Discarding
imported cases, the continuous-time version of our
renewal process (1) is written as
c t R c t g di ij j
j
( ) ( ) ( ) .    0 (6)
Equation (6) assumes that the generation time is
shared among sub-populations. If we further assume
that the intrinsic growth rate r is identical among sub-
populations then the incidence ci(t) can be written as
([33]):
c t k rti i( ) exp( )  (7)
where k is constant and ωi is the leading eigenvector
of the next-generation matrix. Replacing the right-hand
side of (7) in (6) leads to
    i ij j
j
R r g d  exp( ) ( ) .0 (8)
That is,
     R r g dexp( ) ( )0 (9)
and thus the estimator of R is given by 1/M(-r) (see
Background) [16]. Hence, and not surprisingly, as long
as the intrinsic growth rate and generation time are the
same among sub-populations, the estimator of R for the
multi-type epidemic model can be identical to that of
single-host epidemic model [34].
The incorporation of additional levels of detail into the
basic model used to generate growth estimates depends
on the model’s ability to capture the underlying transmis-
sion dynamics in the data and the purposes of the research
questions or public health policymaking goals. These
issues are particularly relevant when a clustering of cases
is observed [35,36]; as we saw in Japan, clusters of cases
caused a delay in accurately estimating the true population
average of transmissibility. The epidemic growth rate
remains a useful quantity for estimating the transmission
potential at the population level in the absence of obvious
clusters of cases and as long as the approximately mod-
elled transmission sufficiently captures the actual hetero-
geneity. We start from the premise that the use of
heterogeneous mixing models is essential in the assess-
ment of critical theoretical claims and policymaking deci-
sions. Hence, it is worth noticing that in this context,
technical questions remain regarding the use and applic-
ability of the exponential growth rate. They include (i) the
development of methods for estimating the generation
time distribution and (ii) the determination of an appro-
priate length of the exponential growth period [37-39].
How should we communicate the estimate?
Without doubt R is the most widely used measurement
of transmissibility and there are many good reasons why
this is so. It has a simple formula and it is the simplest
and most interpretable quantity to communicate to
non-experts. Its limitations become evident when speci-
fic decisions must be made including, for example, who
should be vaccinated first. Precise estimates of the next-
generation matrix capture detailed epidemic dynamics
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that are key to answering questions like the one posed,
but its estimation requires age- and risk-group struc-
tured data and a clear identification of the correct expo-
nential growth time window. In the context of the
pandemic from 2009, gathering age-specific transmission
dynamics information is of the utmost relevance to pre-
diction and policymaking. For instance, given that R =
1.28, one may predict the final size of epidemic, z, the
proportion of those who will experience infection by the
end of epidemic, by using the final size equation (based
on a homogeneous mixing model),
z zR  1 0exp( ). (10)
Iteratively solving (10), z is estimated to be 40.3%.
Similarly, R = 2.3 for a homogeneously mixing popula-
tion is translated to z = 86.2%. Nevertheless, if we have
the next-generation matrix, Rij, the final size zi of host i
is written as ([40])
z z Ri j ij
j
  1 exp( ). (11)
Using our estimate in (5), the corresponding z1-z6 are
estimated at 16.2, 37.1, 47.7, 29.0, 8.7 and 1.0%, respec-
tively. Using the age-specific population size Ni, the final
size z for the entire population is calculated as the
weighted average,
z
ziNi
i
N j
j


 . (12)
Extracting the age-specific population estimate in
Japan [41], z is estimated at 17.5%, not surprisingly
much less than predicted by (10), a value that is indeed
close to the actual range of the impact of first pandemic
wave in Northern Hemisphere countries [17]. The “real”
value of z may be even smaller if we account for addi-
tional levels of heterogeneity in transmission. The repro-
duction number, R, for the entire population may be
useful for obtaining a rough estimate of how much vac-
cine we need (e.g., deciding the total number of vaccines
to be manufactured), while Rij is far more essential for
structuring the most effective strategy of vaccination
and planning the optimal prioritization schemes [42,43].
Given that R can also be calculated from Rij, communi-
cating Rij rather than R to the general public would be
the most informative strategy of science communication
for modelling results. When one explains the concept of
Rij to non-experts, it’s ideal to mention the limitation
due to its nature of approximation because of limita-
tions in structured data in any empirical observation.
The case fatality ratio (CFR), an epidemiological mea-
surement of virulence, would also benefit from the use
of detailed (e.g., age-structured) information. Whereas
the confirmed CFR (cCFR) for the entire population
conditioned on confirmed cases has been estimated at
approximately 0.5% during the very early stage of the
pandemic [1,44,45], the symptomatic CFR (sCFR), which
is conditioned on symptomatic cases, later appeared to
be 0.048% [46]. The CFR estimate for the entire popula-
tion is regarded as a summary measure of virulence, so
the reduced order of virulence (approximately by a fac-
tor of 10) provides not only more accurate information
but a more useful measure for assessing the impact of
this pandemic. Nevertheless, knowledge based on addi-
tional information would be even more useful. Ideally,
we would like to compare epidemiologically the viru-
lence between different settings (e.g., comparison
between age groups or countries) and to use this knowl-
edge in the development of relevant public health policy.
Understanding the heterogeneous risks of death by age-
and risk-groups is critical in the effective design of
intervention strategies. In other words, apart from dis-
cussing the changing assessment of the CFR as a whole,
CFRi for age-group i is probably more informative than
CFR for the entire population.
Conclusions
We analysed the temporal distribution of the influenza
A (H1N1) 2009 epidemic in Japan from May-July 2009,
estimating the reproduction number for the time period
from 29 May to 14 July – a follow-up to our earlier esti-
mates derived primarily from data on school outbreaks
in May. The updated estimate of R, an average over a
wider spectrum of the Japanese population, ranged from
1.21 to 1.35. Our higher estimate reported in [5] was
based on a data set that was incapable of quantifying
the next-generation matrix for the whole country from
the growth rate of cases in a restricted school setting
alone. The upshot of this analysis is tied to the fact that
in regions where disease transmission is highly heteroge-
neous the initial conditions will have a strong effect on
the variation in estimates of the rate of epidemic
growth. To quantify R and Rij appropriately from the
growth rate of cases, it is essential that the model not
only captures the underlying transmission dynamics
behind the empirical data but also that we have suffi-
ciently structured data for each sub-population to esti-
mate the role of variability in our estimates. In addition
to extending the window in time for developing accurate
population level measurements [39], it may be useful to
examine additional epidemiological information (e.g.,
active surveillance of local transmission patterns and the
severe portion of cases including hospital admissions).
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Communicating R to non-experts is simpler than Rij,
but Rij contains the information that is most useful for
the development of specific intervention efforts. Devel-
oping simple interpretations and effective ways of com-
municating Rij (i.e., the average number of secondary
cases in host i generated by a single primary case in
host j) must be pursued. This retrospective study high-
lights the importance of incorporating the concept of
heterogeneous risks of infection and death in the con-
text of the assessment of pandemic potential.
List of abbreviations
R: the reproduction number; RT-PCR: Reverse transcrip-
tion polymerase chain reaction; CI: confidence intervals;
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